论文部分内容阅读
康禾立丰今年的销量还不错,与去年同期相比增加了36%。但在总经理赵商洛看来,离他们预期的50%还是有一定差距的。据赵商洛分析,根据这两年康禾立丰市场基础和产品结构,在市场上的客户和农民对他们产品的认可,以及公司的服务等各个方面因素调研得出应该按50%增长。现在只增长36%是受到一些因素的影响没有达到目标,但整体还比较满意。据了解,陕西康禾立丰生物科技药业有限公司属国家生物农药定点生产企业,是一家集研发、生产、销售、
Kang Wo Li Fung sales this year, not bad, an increase of 36% compared with the same period last year. However, according to Zhao Shangluo, general manager, there is still a certain gap from their expected 50%. According to Zhao Shangluo analysis, based on the past two years, Kanghe Li & Fung’s market fundamentals and product mix, market and customer acceptance by farmers and farmers, and other aspects of the company’s service research and other factors that should be 50% increase. The current increase of only 36% is affected by a number of factors and has not achieved its goal, but the overall situation is still relatively satisfactory. It is understood that Shaanxi Kang Wo Li Fung Biotechnology Pharmaceutical Co., Ltd. is a national biopesticide sentinel production enterprises, is a collection research and development, production, sales,